Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03855878

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

Monoclonal Gammopathy of Undetermined Significance Clinical Trial

Official title:
Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery

Clinical Trial Summary

Screening study to determine incidence of MGUS in this patient population

Clinical Trial Description

This study is designed to observe the incidence of monoclonal gammopathy of undetermined significance (MGUS) among obese patients planning to have weight reduction surgery or planning to enter into a physician monitored weight loss program and to follow the regression or progression of MGUS following surgery or the initiation of the weight loss program. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03855878
Study type Observational
Source Indiana University
Contact
Status Active, not recruiting
Phase
Start date November 8, 2018
Completion date August 8, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05969821 - Clonal Hematopoiesis of Immunological Significance
Not yet recruiting NCT04702932 - Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
Active, not recruiting NCT03327597 - Iceland Screens, Treats or Prevents Multiple Myeloma N/A
Completed NCT01588015 - Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Phase 1
Completed NCT04439006 - Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization Phase 1
Completed NCT01955395 - Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma N/A
Completed NCT01219010 - A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma Phase 1
Completed NCT01237054 - Imaging in MGUS, SMM and MM Phase 2
Recruiting NCT05640843 - A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) N/A
Completed NCT00099047 - Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma Phase 2
Completed NCT00919139 - S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. N/A
Not yet recruiting NCT05114109 - Isatuximab in Type I Cryoglobulinemia Phase 2
Recruiting NCT04114084 - Sleep Apnea in Patients With MGUS and MM
Recruiting NCT06383143 - Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Withdrawn NCT01571726 - Imaging Studies and the Development of Multiple Myeloma Phase 2
Recruiting NCT01408225 - Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Recruiting NCT05136807 - Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Active, not recruiting NCT04920084 - A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) N/A
Recruiting NCT06046287 - Daratumumab for Polyneuropathy Associated With MGUS Phase 2
Recruiting NCT03119883 - Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma N/A